Cahoots Theatre, in collaboration with the Alzheimer Society of Toronto, presents Love and the Trick of Time, an innovative and deeply moving multidisciplinary production. Directed by Tanisha Taitt ...
Nanyang Technological University, Singapore (NTU Singapore) spin-off company Gray Matter Solutions is partnering with Osler ...
Smith and Dani Blum Over a decade ago, a smattering of studies suggested that early cousins of drugs like Ozempic and Mounjaro could prevent, or even reverse, signs of Alzheimer’s disease in mice.
The Alzheimer’s Society notes that people living with dementia tend to have sleep issues, but the evidence is currently unclear on whether poor sleep is a risk factor for the disease.
Johanna Jackson studied several conditions, including epilepsy and brain injury, before focusing on Alzheimer’s disease. The constant throughout her career is an interest in synapses – the small ...
Past research has shown that viral infections can trigger systemic inflammation, a key factor in neurodegenerative diseases such as Alzheimer’s disease. Emerging evidence suggests that people ...
Most of our school resources create Dementia Friends, which is an Alzheimer’s Society initiative changing the way people think, act and talk about dementia. There are already millions of Dementia ...
Jan. 29, 2025 — Research comparing different approaches to dementia care for people with Alzheimer's disease and other dementias found no significant differences in patient behavioral symptoms ...
Researchers Create New Guidelines to Diagnose Common Memory Disorder Frequently Mistaken for Alzheimer's Disease Jan. 22, 2025 — New guidelines will help doctors identify patients with a common ...
Amid its wooden shelves of clothing, accessories and tchotchkes, the sales clerks were, like Ms. Dolan, staff members trained to interact effectively with residents with dementia. “Great choice ...
Leerink Partners analyst Puneet Souda has maintained their bullish stance on DHR stock, giving a Buy rating yesterday. Puneet Souda’s rating is based on Danaher’s recent announcement regarding ...
or mild cognitive impairment due to Alzheimer’s disease and mild AD, in the European Union, or EU. In November 2024, a positive opinion was received from the Committee for Medicinal Products for ...